Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	TDT High Dose	29
Overall Study	STARTED	TDT Low Dose	25
Overall Study	STARTED	TDT Placebo	20
Overall Study	STARTED	NTDT High Dose	24
Overall Study	STARTED	NTDT Low Dose	12
Overall Study	STARTED	NTDT Placebo	12
Overall Study	COMPLETED	TDT High Dose	18
Overall Study	COMPLETED	TDT Low Dose	16
Overall Study	COMPLETED	TDT Placebo	16
Overall Study	COMPLETED	NTDT High Dose	10
Overall Study	COMPLETED	NTDT Low Dose	8
Overall Study	COMPLETED	NTDT Placebo	6
Overall Study	NOT COMPLETED	TDT High Dose	11
Overall Study	NOT COMPLETED	TDT Low Dose	9
Overall Study	NOT COMPLETED	TDT Placebo	4
Overall Study	NOT COMPLETED	NTDT High Dose	14
Overall Study	NOT COMPLETED	NTDT Low Dose	4
Overall Study	NOT COMPLETED	NTDT Placebo	6

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04411082/flow